TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thought the Goldman Sachs (GS) downgrade of Johnson & Johnson (JNJ) was questionable. Johnson & Johnson had a very good acquisition and Cramer doesn't advice people to sell and then get back in at $127. 

Watch More with TheStreet:

More from Video

What's My Data Doing in the Cloud? -- 60 Seconds

What's My Data Doing in the Cloud? -- 60 Seconds

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray